SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-24-033949
Filing Date
2024-03-13
Accepted
2024-03-13 16:30:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G tm248577d1_sc13g.htm SC 13G 56408
  Complete submission text file 0001104659-24-033949.txt   58182
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Subject) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87951 | Film No.: 24746345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address THISTLE HOUSE, 4 BURNABY STREET HAMILTON D0 HM11
Business Address THISTLE HOUSE, 4 BURNABY STREET HAMILTON D0 HM11 847-932-7900
AbbVie Biotechnology Ltd (Filed by) CIK: 0002014668 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SC 13G